Professional Documents
Culture Documents
Seminar - Rad5 - A Systematic Study On The Mesomorphic Behavior of Asymmetrical 1-Alkyl-3-Dodecylimidazolium Bromides
Seminar - Rad5 - A Systematic Study On The Mesomorphic Behavior of Asymmetrical 1-Alkyl-3-Dodecylimidazolium Bromides
pubs.acs.org/crystal
© 2014 American Chemical Society 1561 dx.doi.org/10.1021/cg401396n | Cryst. Growth Des. 2014, 14, 1561−1571
Crystal Growth & Design Article
changes in physicochemical properties of ILs bearing one (98%), and 1-octylimidazole (98%) were purchased from IoLiTec
dodecyl unit still needs to be explored to facilitate the (Heilbronn, Germany). 1-Ethylimidazole (95%), 1-butylimidazole
molecular design of ILCs. Furthermore, previous investigations (98%), imidazole (99.5%), sodium hydride (95%), and all 1-
of imidazolium-based ILs and ILCs have mostly focused on bromoalkanes were purchased from Sigma-Aldrich (Steinheim,
Germany). All chemicals were used as received without further
even numbered chain lengths; ILs or ILCs with odd number
purification.
alkyl chains are very seldom reported. 1-Dodecylimidazole was synthesized using a reported procedure.20
For this reason, a series of 1-alkyl-3-dodecylimidazolium After the purification procedure, the product was obtained as a yellow-
bromides ([CnC12IM]Br, n = 0 − 13) was investigated. The brownish oil. Experimental details are provided in Supporting
influence of these systematic structural variations on the Information. Yield = 71%. 1H NMR (298 K, 200 MHz, DMSO-d6):
physicochemical properties was studied, focusing on their δ [ppm] = 0.86 (3H, t), 1.04−1.46 (14H, m), 1.64−1.83 (2H, m),
thermal behavior and liquid crystalline properties. The thermal 3.71−4.09 (2H, m), 6.92 (2H, dd), 7.43 (1H, s).
and structural properties were investigated via differential [C0C12]Br was prepared by dropwise addition of a slight excess of
scanning calorimetry (DSC), polarizing optical microscopy concentrated hydrobromic acid (4 mL) to 1-dodecylimidazole at 0 °C
(POM), and temperature dependent X-ray diffraction (SAXS). (1.0 g, 4.2 mmol) in diethyl ether. The bromide salt precipitated as a
For convenience, we use the same designations for the white solid after cooling at −30 °C overnight. Unlike [C0C13]Br,22
[C0C12]Br was highly hygroscopic. The product was filtered under
compounds as is used in our previous report.22 The compounds
inert environment, washed repeatedly with ethyl acetatem and dried in
are named by the number of carbon atoms in the two alkyl a vacuum for at least 3 days at 60 °C. Yield = 48%. 1 H NMR (200
chains at the first and third positions of the imidazolium ring. MHz, DMSO-d6): δ [ppm] = 0.83 (3H, t), 1.22 (22H, m), 1.78 (2H,
For example, [C5IMC12]Br, 1-pentyl-3-dodecylimidazolium t), 4.16 (2H, t), 7.68 (1H, s), 7.78 (1H, s), 9.15 (1H, s). ESI-MS
bromide, as C5C12 and [C6IMC12]Br, 1-hexyl-3-dodecylimi- (positive, ([%])) m/z = 265.1 [M − Br]+ (100).
dazolium bromide, as C6C12. C5C12, C7C12, C9C12, C10C12, C11C12, C12C12, and C13C12
were synthesized with the general method for 1,3-dialkylimidazolium
2. EXPERIMENTAL SECTION bromides via direct alkylation of the respective 1-dodecylimidazole
with alkyl bromide in a 1:1.1 molar ratio in acetonitrile.23
2.1. Sample Preparation. The synthesis and sample handling of Syntheses of C1C12, C2C12, C3C12, C4C12, C6C12, and C8C12
anhydrous salts were carried out using standard Schlenk and argon- followed the same procedure except 1-methylimidazole, 1-ethyl-
glovebox techniques. All the bromide compounds were hygroscopic. imidazole, 1-propylimidazole, 1-butylimidazole, 1-hexylimidazole, and
The samples were dried under 10−6 mbar at 60 °C for 3 days. All the 1-octylimidazole were alkylated using 1-bromododecane.
sample preparations for further analytics were carried out in an argon- Compounds C0C12, C1C12, and C2C12 were obtained as
glovebox. crystalline solids; compounds C3C12, C4C12, and C5C12 are viscous
2.2. Synthesis. Acetonitrile (99.5%), ethyl acetate (95%), room temperature ionic liquids (RTILs); C6C12 is obtained as a
methanol (99%), dichloromethane (99.9%), and tetrahydrofuran crystalline solid, while C7C12, C8C12, C9C12, and C10C12 are
(extra dry, >99%) were used as received from J.T. Backer (Deventer, viscous liquids or wax-like solids. The analytical data are reported
Holland). Hydrobromic acid (47%) was obtained from Merck below.
(Darmstadt, Germany). 1-Propylimidazole (98%), 1-hexylimidazole [C1C12]Br was synthesized from 1-methylimidazole (2.5 g, 30.0
mmol) and 1-bromododecane (8.3 g, 33.0 mmol). Yield = 91%. 1H
Scheme 1. 1-Alkyl-3-dodecylimidazolium Cations under NMR (298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.82 (3H, t), 1.20
Investigationa (17H, m), 1.74(2H, t), 3.81 (s, 3H), 4.17 (2H, t), 7.61 (2H, s), 9.27
(1H, s). ESI-MS (positive, ([%])) m/z = 251.1 [M − Br]+ (100).
[C2C12]Br was synthesized from 1-ethylimidazole (3 g, 29.6 mmol)
and 1-bromododecane (7.4 g, 30.0 mmol). Yield = 90%. 1H NMR
(298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.84 (3H, m), 1.23 (18H,
m), 1.41(3H, t), 1.77 (m, 2H), 4.17 (4H, qn), 7.78 (2H, m), 9.21 (1H,
s). ESI-MS (positive, ([%])) m/z = 268.3 [M − Br]+ (100).
[C3C12]Br was synthesized from 1-propylimidazole (2.5 g, 23.4
mmol) and 1-bromododecane (6.3 g, 25.7 mmol). Yield = 72%. 1H
NMR (298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.83 (6H, m), 1.22
(18H, m), 1.78 (4H, m), 4.13 (4H, m), 7.81 (2H, s), 9.27 (1H, s).
ESI-MS (positive, ([%])) m/z = 282.3 [M − Br]+ (100).
[C4C12]Br was synthesized from 1-butylimidazole (3 g, 24.2 mmol)
and 1-bromododecane (6.6 g, 26.6 mmol). Yield = 84%. 1H NMR
(298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.86 (6H, m), 1.22 (22H,
m), 1.77 (4H, m), 4.17 (4H, m), 7.80 (2H, m), 9.27 (1H, s). ESI-MS
(positive, ([%])) m/z = 296.1 [M − Br]+ (100).
[C5C12]Br was synthesized from 1-dodecylimidazole (3 g, 12.7
mmol) and 1-bromopentane (2.1 g, 13.9 mmol). Yield = 84%. 1H
NMR (298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.84 (6H, m), 1.22
(24H, m), 1.79 (4H, m), 4.16 (4H, m), 7.82 (2H, m), 9.29 (1H, s).
ESI-MS (positive, ([%])) m/z = 310.3 [M − Br]+ (100).
[C6C12]Br synthesized from 1-hexylimidazole (3 g, 19.3 mmol)
and 1-bromododecane (5.0 g, 20.0 mmol). Yield = 84%. 1H NMR
(298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.84 (6H, m), 1.22 (26H,
m), 1.78 (4H, m), 4.16 (4H, m), 7.81 (2H, s), 9.29 (1H, s). ESI-MS
(positive, ([%])) m/z = 324.4 [M − Br]+ (100).
[C7C12]Br was synthesized from 1-dodecylimidazole (3 g, 12.7
mmol) and 1-bromoheptane (2.5 g, 13.9 mmol). Yield = 84%. 1H
a
Bromide was used as the counter ion. NMR (298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.84 (6H, m), 1.22
(28H, m), 1.78 (4H, m), 4.16 (4H, m), 7.80 (2H, s), 9.25 (1H, s). peaks at positive heat flow. DSC runs included heating and subsequent
ESI-MS (positive, ([%])) m/z = 338.3 [M − Br]+ (100). cooling at 5 °C/min. Given temperatures correspond to the onset of
[C8C12]Br synthesized from 1-octylimidazole (3 g, 16.3 mmol) and the respective thermal process.
1-bromododecane (4.1 g, 16.5 mmol). Yield = 67%. 1H NMR (298K, 2.8. Polarizing Optical Microscopy. The POM pictures of
200 MHz, DMSO-d6) δ [ppm] = 0.84 (6H, m), 1.22 (30H, m), 1.78 mesophases were acquired with an Axio Imager A1 microscope (Carl
(4H, m), 4.16 (4H, m), 7.80 (2H, s), 9.30 (1H, s). ESI-MS (positive, Zeiss MicroImaging GmbH, Göttingen, Germany) equipped with a
([%])) m/z = 352.4 [M − Br]+ (100). hot stage, THMS600 (Linkam Scientific Instruments Ltd., Surrey,
[C9C12]Br was synthesized from 1-dodecylimidazole (3 g, 12.7 UK), and a Linkam TMS 94 (Linkam Scientific Instruments Ltd.,
mmol) and 1-bromononane (2.9 g, 13.9 mmol). Yield = 91%. 1H Surrey, UK) temperature controller and crossed polarizers. Images
NMR (298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.84 (6H, m), 1.22 were recorded at a magnification of 100× as video with a digital
(32H, m), 1.78 (4H, m), 4.15 (4H, m), 7.80 (2H, s), 9.23 (1H, s). camera after initial heating during the cooling stage. Heating and
ESI-MS (positive, ([%])) m/z = 366.2 [M − Br]+ (100). cooling rates were 5 K/min−1. For the measurement, the samples were
[C10C12]Br was synthesized from 1-dodecylimidazole (3 g, 12.7 placed under argon between two coverslips which were sealed with
mmol) and 1-bromodecane (3.1 g, 13.9 mmol). Yield = 90%. 1H NMR two-component adhesive (UHU plus 300, UHU GmbH & Co. KG,
(298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.84 (6H, m), 1.22 (34H, Bühl, Germany).
m), 1.78 (4H, m), 4.12 (4H, m), 7.81 (2H, s), 9.27 (1H, s). ESI-MS
(positive, ([%])) m/z = 380.3 [M − Br]+ (100). 3. RESULTS AND DISCUSSION
[C11C12]Br was synthesized from 1-dodecylimidazole (3 g, 12.7 3.1. Structural Analysis. Single crystals of compound
mmol) and 1-bromoundecane (3.3 g, 13.9 mmol). Yield = 90%. 1H
NMR (298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.84 (6H, m), 1.22
C2C12 could be obtained from cooling the molten compound
(36H, m), 1.77 (4H, m), 4.15 (4H, m), 7.80 (2H, s), 9.23 (1H, s). to room temperature in the form of flat, colorless needles.
ESI-MS (positive, ([%])) m/z = 394.3 [M − Br]+ (100). Experiments to obtain single crystals of the other compounds in
[C12C12]Br was synthesized from 1-dodecylimidazole (3 g, 12.7 this series of sufficient quality for X-ray structure analysis failed
mmol) and 1-bromododecane (3.5 g, 13.9 mmol). Yield = 85%. 1H so far. Compound C2C12 crystallizes unexpectedly in the
NMR (298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.82 (6H, m), 1.22 triclinic space group P(1̅) (No. 2), not isotypic with C2C11,22
(38H, m), 1.77 (4H, m), 4.16 (4H, m), 7.81 (2H, s), 9.25 (1H, s). which crystallizes in the monoclinic space group P21/c (No.
ESI-MS (positive, ([%])) m/z = 408.1 [M − Br]+ (100). 14). Crystallographic data, data collection, and structure
[C13C12]Br was synthesized from 1-dodecylimidazole (2 g, 9.5 refinement details are given in Table 1. The asymmetric unit
mmol) and 1-bromotridecane (2.8 g, 10.5 mmol). Yield = 88%. 1H
NMR (298 K, 200 MHz, DMSO-d6) δ [ppm] = 0.85 (6H, m), 1.22
(42H, m), 1.78 (2H, m), 4.18 (4H, m), 7.80 (2H, s), 9.22 (1H, s). Table 1. Crystallographic and Refinement Details for C2C12
ESI-MS (positive, ([%])) m/z = 422.4 [M − Br]+ (100). empirical formula C17H33BrN2
2.3. 1H NMR Spectra. were recorded on a Bruker DPX 250b
formula weight 345.35 g/mol
(operating at 200.1 MHz for 1H) (Bruker, Germany).
crystal system triclinic
2.4. ESI Mass Spectra. were recorded on an Esquire 6000
instrument (Bruker, Karlsruhe, Germany) applying the following space group P1̅
parameters: sputtering voltage 4 kV; nebulizer pressure 10−20 psi; unit cell a = 11.0090 Å; b = 12.1650 Å; c = 23.1770 Å;
dimensions α = 94.727°; β = 95.591°; γ = 110.903°
drying gas 5−10 L/min, 300 °C; flow rate 240 μL/h. For all mass
spectrometric measurements, the ILs samples were prepared as 1 mg/ volume 2862.9 Å
mL solutions in acetonitrile. Z 6
2.5. Crystal Structure Analysis. Crystals of [C2C12]Br were temperature 170 K
obtained by cooling the molten compound to room temperature. calculated density 1.20 mg/cm3
Suitable single crystals were sealed in Lindeman glass capillaries. All absorption 2.149 mm−1
data were collected on a Stoe IPDS-I single-crystal X-ray coefficient
diffractometer with graphite monochromated Mo Kα radiation (λ = Θ-range for data 2.3 to 25.0°
0.71073 Å at 170 K). Crystal structure solution by direct methods collection
using SIR 92 yielded the heavy atom positions. Refinement with reflections 9477/6258
SHELXL-97 allowed for the localization of the remaining atom collected/
unique
positions. Hydrogen atoms were added and treated in the riding atom
mode. Data reduction was carried out with the program package X- refinement full-matrix least-squares on F2
method
Red, and numerical absorption correction was carried out with the
data/parameters 6258/547
program X-Shape. To illustrate the crystal structures, the program
Diamond 3 was used. goodness-of-fit on 0.785
F2
2.6. Temperature-Dependent SAXS Experiments. Small-angle
final R indices R1 = 0.029; wR2 = 0.056
X-ray scattering (SAXS) measurements were carried out at the A2 [I > 2σ(I)]
Beamline of DORIS III, Hasylab, DESY, Hamburg, Germany, at a fixed R indices (all R1 = 0.055; wR2 = 0.060
wavelength of 1.5 Å. The data were collected with a MarCCD data)
detector. The detector was calibrated with silver behenate. The
sample−detector position was fixed at 635.5 mm. For measurements,
the samples were placed in a copper sample holder between aluminum contains three crystallographically independent [C2C12]+
foil. The sample temperature was controlled by a JUMO IMAGO 500 cations and three Br− as counterions (Figure 1). In contrast
multichannel process and program controller. Data reduction and to compound C2C11, in which all undecyl chains form a linear
analysis, correction or background scattering and transmission were structure of favored all-trans configurations, in C2C12 distinct
carried out by using the program a2tool (Hasylab).
differences conformations of each of the three crystallo-
2.7. Differential Scanning Calorimetry (DSC). The DSC
measurements were performed with a computer-controlled Phoenix graphically independent cations in the asymmetric unit are
DSC 204 F1 thermal analyzer (Netzsch, Selb, D) with argon as apparent.
protection gas. The samples were placed in aluminum pans which were One of the cations can be characterized by a rodlike shape
cold-sealed under argon. Experimental data are displayed in such a way with one dodecyl chain and one ethyl chain being almost
that exothermic peaks occur at negative heat flow and endothermic perpendicular to the imidazolium core plane. Both starting C
1563 dx.doi.org/10.1021/cg401396n | Cryst. Growth Des. 2014, 14, 1561−1571
Crystal Growth & Design Article
atoms in the two alkyl chains are located in the same plane as
the imidazolium core. The dodecyl chain and imidazolium core
plane form an angle (defined as the angle between the Figure 2. Packing diagram of C2C12. View along the crystallographic
imidazolium ring centroid and the terminal C atom of alkyl b axis (top) and a axis (bottom).
chain) of 95°. The terminal C atom of ethyl chain is tilted with
respect to the imidazolium ring at an angle of 111°. The
dodecyl chain shows all-trans conformation, aside the bond
between the first and the second C atoms, which exhibits a
trans−gauche conformation with a torsion angle of 62°. The
imidazolium core plane is almost parallel to the ab plane,
forming an angle of 6°.
In the second [C2C12]+ cation, the angle between the
dodecyl chain and imidazolium core plane increases to 143°.
The terminal C atom of ethyl chain forms an angle of 110° with
respect to the imidazolium. The dodecyl chain adopts an all-
trans conformation. The imidazolium core plane tilts with
respect to the ab plane at an angle of 59°.
The third [C2C12]+ cation adopts a similar conformation to
the second one, aside from a gauche conformation around the
bond between the second and the third C atoms in the dodecyl
chain, with a torsion angle of 74°. The angle between the
imidazolium core plane and the ab plane is 76°.
The all-trans sections of the dodecyl chains belonging to the
first and second cations lie in planes roughly parallel to one
another and to the crystallographic a-axis, while that of the
third cation lies roughly parallel to the crystallographic b-axis.
Compound C2C12 forms a layered structure, in which
hydrophilic and hydrophobic regions can be observed. The
hydrophobic regions are formed by interdigitated dodecyl
chains of imidazolium cations with a repeating layer distance of
25.4 Å. Three cations form a unit, and units layer with different
orientations (Figure 2). The interdigitation is observed in both
the crystallographic ac and bc planes. The hydrophilic regions
are formed by the charged imidazolium cations with the ethyl
chains and bromide anions. Nonclassical hydrogen bonds
between cations and anions can be discussed. Five neighboring
imidazolium rings can be connected to a bromide anion via Figure 3. Hydrogen bonding interactions in detail for C2C12 (top);
hydrogen bonds. Not only the protic C-positions on the conformations of the cation units, due to hydrogen bonding (middle
imidazolium cores but also protons from both starting C atoms and bottom).
on ethyl and dodecyl chains participate the hydrogen bonding
(Figure 3, top). The hydrogen bonds force the trication units to
take the following conformation: the imidazolium ring in the tilting angle of 70° (Figure 3, middle); the two imidazolium
first cation facing the imidazolium core in the third one, with a rings of the second cations stay parallel to each other and take a
1564 dx.doi.org/10.1021/cg401396n | Cryst. Growth Des. 2014, 14, 1561−1571
Crystal Growth & Design Article
Figure 7. DSC scans for C7C12, C8C12, C9C12, and C10C12 at 5 K/min.
chains. For n > 6, the cohesive intermolecular interactions group. Remarkably, C6C12 exhibits a similar melting point to
through van der Waals forces rise with each additional −CH2− those of C0C12, C1C12, and C2C12. This indicates the hexyl
1567 dx.doi.org/10.1021/cg401396n | Cryst. Growth Des. 2014, 14, 1561−1571
Crystal Growth & Design Article
Figure 11. Polarizing optical microscopy images: (a) C0C12 at 56 °C; (b) C1C12 at 67 °C; (c) C3C12 at −8 °C; (d) C4C12 at −10 °C; (e)
C5C12 at −20 °C; (f) C7C12 at 0 °C; (g) C8C12 at 25 °C; (h) C9C12 at 40 °C; (i) C10C12 at 60 °C; (j) C11C12 at 70 °C; (k) C12C12 at 60 °C;
(l) C13C12 at 40 °C.
Table 3. Layer Distances d/Å in the Crystalline States and the Liquid Crystalline Phases
C0C1 C1C12 C2C12 C3C12 C4C12 C5C12 C6C12
dCr [Å] 20.6 24.4 26.2 b b b 16.5
dLC [Å] 29.9 29.5 a 29.6 24.8 25.0 a
C7C12 C8C12 C9C12 C10C12 C11C12 C12C12 C13C12
dCr [Å] 25.4 26.8 28.3 25.8 27.4 19.1 24.2
dLC [Å] 23.3 23.4 23.3 23.9 25.5 28.0 33.4
■
crystalline states. The layer spacing in crystalline states is plotted in
black and in liquid crystalline phases in red. Only the d values obtained
from the (001) reflections are shown. For compounds C2C12 and ASSOCIATED CONTENT
C6C12, no mesophase was observed. For compound C3C12 and *
S Supporting Information
C4C12, and C5C12, no layer spacing could be measured due to the Table S1: Thermal behavior of n-alkyl-dodecylimidazolium
experimental limits and low crystallization temperatures. For bromide ionic liquids and ionic liquid crystals; SAXS
compounds exhibiting more than one crystalline polymorph at low
measurements; synthesis of 1-dodecylimidazole; crystallo-
temperatures, only the d spacing at room temperature was given.
graphic information file. This material is available free of
charge via the Internet at http://pubs.acs.org.
■ AUTHOR INFORMATION
Corresponding Author
*E-mail: anja.mudring@ruhr-uni-bochum.de. Tel: +49-234-32-
27408.
Notes
The authors declare no competing financial interest.
■ ACKNOWLEDGMENTS
This work was supported by the German Science Foundation
DFG through the priority program 1191“Ionic Liquids”, the
DFG Cluster of Excellence RESOLV, and the DESY
(Deutsches Elektronensynchrotron Proposal No. I-
20100011). We thank Dr. Sergio Funari for support during
the SAXS measurements and thank Dr. P. Campbell for helpful
comments.
Figure 13. Illustration of the changes in the molecular arrangement of
C0C12 and C12C12 from the crystalline state to the mesophase. ■ REFERENCES
(1) Binnemans, K. Chem. Rev. 2005, 105, 4148−4204.
(2) Holbrey, J. D.; Rogers, R. D. In Ionic Liquid in Synthesis;
The liquid crystalline properties of mesomorphic compounds Wasserscheid, P., Welton, T., Eds.; Wiley-VCH, Weinheim, 2008; Vol.
were examined by differential scanning calorimetry and 1, pp 57−88.
polarized optical microscopy. Combing the informations (3) Tokuda, H.; Hayamizu, K.; Ishii, K.; Susan, M. A. B. H.;
obtained from POM images and X-ray scattering experiments Watanabe, M. J. Phys. Chem. B 2005, 109, 6103−6110.
at small angle range, the mesophases that they form can be (4) Tokuda, H.; Hayamizu, K.; Ishii, K.; Susan, M. A. B. H.;
identified as the smectic phase for these compounds. Watanabe, M. J. Phys. Chem. B 2004, 108, 16593−16600.
Observations from SAXS measurements indicate that C0C12, (5) Welton, T. Chem. Rev. 1999, 99, 2071−2083.
C1C12, C12C12, and C13C12 form smectic A phase, while (6) Holbrey, J. D.; Seddon, K. R. J. Chem. Soc., Dalton Trans. 1999,
C7C12, C8C12, C9C12, C10C12, and C11C12 show smectic 2133−2140.
(7) Wasserscheid, P.; Keim, W. Angew. Chem., Int. Ed. 2000, 39,
C formations. Unequivocal mesophase identification for 3772−3789.
compounds C3C12, C4C12, and C5C12 is not possible due (8) Yamanaka, N.; Kawano, R.; Kubo, W.; Masaki, N.; Kitamura, T.;
to the low temperature transitions lying beyond experimental Wada, Y.; Watanabe, M.; Yanagida, S. J. Phys. Chem. B 2007, 111,
limits. 4763−4769.
Finally, no thermic mesophase formation was observed for (9) Axenov, K. V.; Laschat, S. Materials 2011, 4, 206−259.
C2C12 and C6C12. However, both of the compounds contain (10) Taubert, A. Angew. Chem., Int. Ed. 2004, 43, 5380−5382.